Company
Headquarters: Singapore, Singapore
S$230.2 Million
SGD as of July 1, 2024
US$169.6 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
ISEC Healthcare Ltd., an investment holding company, provides medical care, consultancy, treatment, and surgery services in the field of ophthalmology in Singapore, Malaysia, and Myanmar. The company operates through two segments, Specialised Health Services and General Health Services. It offers a range of eye care services, including cataract and intraocular lens implant surgeries, refractive surgeries, corneal transplant and anterior surgeries, adult strabismus and paediatric ophthalmology, glaucoma diagnostics and therapeutics, medical retinal diseases, uveitis, oculoplastics, facial cosmetics, and aesthetics surgeries, as well as services for vitreous and retinal diseases, external eye diseases, and optometry and orthoptics. In addition, the company offers general medical services. It operates eye care centers in Kuala Lumpur, Malacca, Penang, Johor, and Sibu. ISEC Healthcare Ltd. was incorporated in 2014 and is headquartered in Singapore. ISEC Healthcare Ltd. is a subsidiary of Aier Eye Hospital Group Co., Ltd.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
ISEC Healthcare Ltd has the following listings and related stock indices.
Stock: SGX: 40T wb_incandescent